2014
DOI: 10.1016/j.surg.2013.12.025
|View full text |Cite
|
Sign up to set email alerts
|

Clinical significance of the BRAFV600E mutation in multifocal papillary thyroid carcinoma in Korea

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
19
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 23 publications
(20 citation statements)
references
References 25 publications
1
19
0
Order By: Relevance
“…To date, many studies suggested that Hashimoto's thyroiditis was associated with higher frequency of wild-type BRAF. 12,[23][24][25] In this study, DLI with positive TPOAb was a negative independent factor of BRAF V600E mutation and extrathyroidal extension in PTC but DLI without TPOAb was not. [5][6][7][8] However, there were also many studies that reported the BRAF status was not associated with Hashimoto's thyroiditis, or BRAF V600E mutation was even more frequently observed when Hashimoto's thyroiditis was present.…”
Section: Discussionmentioning
confidence: 46%
“…To date, many studies suggested that Hashimoto's thyroiditis was associated with higher frequency of wild-type BRAF. 12,[23][24][25] In this study, DLI with positive TPOAb was a negative independent factor of BRAF V600E mutation and extrathyroidal extension in PTC but DLI without TPOAb was not. [5][6][7][8] However, there were also many studies that reported the BRAF status was not associated with Hashimoto's thyroiditis, or BRAF V600E mutation was even more frequently observed when Hashimoto's thyroiditis was present.…”
Section: Discussionmentioning
confidence: 46%
“…In this study, the BRAF V600E mutation status of multifocal PTCs was only determined by the dominant tumour, rather than each focus in individuals. Although this approach may be controversial, according previous studies, most multifocal thyroid carcinoma share identical BRAF V600E status, ranging from 59.4-85.7% [31][32][33][34][35]. Additionally, the most common condition for the mixed BRAF V600E mutation tumour group is that the dominant tumour is BRAF-positive while other foci are partly or all BRAF-negative.…”
Section: Discussionmentioning
confidence: 99%
“…Several researches found most of the patients with multifocal PTC had the BRAF V600E mutation in one or more tumor foci and all BRAF V600E -positive multifocal PTC showed more aggressive features [16, 17]. Moreover, many studies have investigated multifocal PTC clonality through a number of approaches, including X-chromosome inactivation, BRAF mutation, RET rearrangements, loss of heterozygosity, or allelic imbalances of distinct cancer foci [1719].…”
Section: Discussionmentioning
confidence: 99%